SCHEMBL6979976

SCHEMBL6979976

CCCC(=O)COc1cc2c(=O)ccn3c4ccc(Br)cc4c(c1)c23

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 3/20 0.34
PPARG P37231 2/20 0.33
PPARA Q07869 2/20 0.33
TSPO P30536 1/20 0.33
CNR2 P34972 1/20 0.32
MGAM O43451 2/20 0.32
GAA P10253 2/20 0.32
SI P14410 2/20 0.32
MGAM2 Q2M2H8 2/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
GSK3B P49841 4/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CA P42336 1/20 0.32
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
IDO1 P14902 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983135 0.88 PTGDR2 (0.39) PTGDR2
SCHEMBL6971985 0.86 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1LMNAGAANPSR1
SCHEMBL6981400 0.85 PSEN1 (0.39) ALDH1A1LMNAMGAMGAASI
SCHEMBL6976583 0.84 LMNA (0.40) SMN1; SMN2ALDH1A1LMNAPPARGPPARA
SCHEMBL6980950 0.83 MCL1 (0.42) ALDH1A1LMNAPPARGPPARAMGAM
SCHEMBL8157626 0.80 POLB (0.36) SMN1; SMN2ALDH1A1LMNATSPOCNR2
SCHEMBL7083107 0.79 IDO1 (0.33) LMNAPPARGPPARAIDO1MAPT
SCHEMBL6982438 0.79 PIK3R1 (0.39) SMN1; SMN2ALDH1A1TSPOGSK3BPIK3R1
SCHEMBL6979890 0.79 CTRC (0.39) PTGDR2
SCHEMBL8157787 0.77 MAOB (0.44) SMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed